TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of participants with symptomatic radiation pneumonitis (grade ≥2)
Endpoint domain: Adverse events/effects
Primary endpoint: Prognosis and treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day biochemically confirmed point prevalence abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in urinary beta-3 adrenoreceptor levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent Time in Range (Baseline)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Time in Range (Week 22-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Acceptability Score (Youth)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in submaximal exercise endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with postdural puncture headache
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mean Asthma Control Test (ACT) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Baseline Respiratory Severity Score (RSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average Respiratory Severity Score (RSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Baseline Electrical Activity of the Diaphragm (Edi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average Baseline Electrical Activity of the Diaphragm (Edi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients receiving both kidney and bone marrow from the same donor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Donor CD3 Tcell chimerism between 30-75% at 45 days post infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knowledge score related to HIV prevention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in attitude score related to HIV prevention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in practice score related to HIV prevention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of serious cardiac arrythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxford Shoulder Score Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Visible Plaque Index (VPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: dmft index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Sensation of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric rating scale (NRS) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Survival of human monocytes
Endpoint domain: Mortality/survival
Primary endpoint: Identification of diagnostic biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Identification of early predictive biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of correct responses in a forced-choice task after vocal stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical values of judgements along a scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response time (second)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-discharge home days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Infection reoccurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Intentions to vaccinate child(ren) against COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child's COVID-19 vaccine uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients completing the program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Individual patient compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from baseline in oscillatory measure of cognitive control during stimulus evaluation in AX-CPT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Auditory Steady-State Response (ASSR) Modulation with Attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cerebral blood flow in auditory control regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of neurosphere formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cortical excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Strength (key pinch and grasp strength)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time of negative detection of SARS-CoV-2 RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Adherence to Follow-up Eye Care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of poor healing of incisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: LFD result (positive/negative) from anterior nares swab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LFD result (positive/negative) from buccal swab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of bowel related adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Memory Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-6 (Interleukin-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TNF-alpha (Tumor necrosis factor-alpha)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-10 (Interleukin-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CK (creatine kinase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of HIV prevention initiative
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of HIV prevention initiative
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to Optimal Antimicrobial Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from time 0 to t (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Grade 2 or higher lower respiratory infections (LRI)
Endpoint domain: Adverse events/effects
Primary endpoint: Composite Bayley IV score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized change in peak aortic jet velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reported Pain of Participants
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incomplete adherence to PDMC doses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Satisfaction with Self-administered DMPA at initiation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with Self-administered DMPA after two injections
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with DMPA Administered in an Office Setting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adapted Client Satisfaction Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intervention Helpfulness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: one year recurrence free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants Who Experience Dose-limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Objective Response Rate (ORR) per Lugano Response Criteria by Blinded Independent Central Review (BICR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Objective Response Rate (ORR) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) by Investigator
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Self-reported knee-related pain, symptoms, function in sport and quality of life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in mean common carotid artery intima-media thickness (CCA-IMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of BCG Vaccine Vial
Endpoint domain: Adverse events/effects
Primary endpoint: Global Mental Health Self-questionnaire (SCL-90 R)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bayley Scales of Infant and Toddler Development (BAYLEY-4)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 6-month postoperative occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mineral contents of enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck Disability Index Urdu version (NDI-U)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cervical Range of Motion using Goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oldenburg Burnout Inventory (OLBI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in Annualized Growth Velocity (AGV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of kidney-protective treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation of newly initiated RAASi or SGLT-2i treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation of ongoing RAASi and/or SGLT-2i treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of acute symptomatic or fatal VTE
Endpoint domain: Mortality/survival
Primary endpoint: Mortality (all-cause)
Endpoint domain: Mortality/survival
Primary endpoint: Recurrent cardiac arrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Persistent/recurrent shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of acute kidney disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Parent Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of neutrophils per liter of blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in knowledge regarding air pollution
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in air pollution preventive health behaviors
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Preoperative and postoperative hemoglobin change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Timeliness of influenza vaccination
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Timeliness of COVID-19 vaccination
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participants with increase in grading for at least one laboratory value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titer (GMT) ratio of antigen 1 antibody in Phase 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titer (GMT) ratio of serum neutralization titers against pseudovirus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Yale Global Tic Severity Scale (YGTSS) - Total Tic Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression (CGI) - Severity Scale Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Yale Global Tic Severity Scale (YGTSS) - Overall Tic Related Impairment Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants completing 12 month study visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Study-related adverse events as assessed by MedDRA v27
Endpoint domain: Adverse events/effects
Primary endpoint: Study-related serious adverse events as assessed by MedDRA v.27
Endpoint domain: Adverse events/effects
Primary endpoint: Phenylalanine levels over 360 µmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signs and symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety metrics
Endpoint domain: Adverse events/effects
Primary endpoint: Relative LDL-C change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Concentration-time From Time Zero to Time Last Qualifiable Concentration (AUC(0-T))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time From Time Zero Extrapolated to Infinite Time (AUC(INF))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Viral Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Biomarker test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathology Recognition Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life t1/2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-prandial muscle protein synthesis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of Pathogenic and Variant Mutations in PFIC Genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knowledge on oral cancer
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: serum creatinine (sCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 24h urine test for creatinine clearance and protein excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in mean neurological disability score (NIHSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in mean functional disability score (mRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: qNOX value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete recovery of facial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between I/Hr and aPTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Correlation between I/Hr and aPTTr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Correlation between I/Hr and anti-Xa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Correlation between I/Hr and ACT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of treatment-emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: readiness for transition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pathologic complete response (PCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural population representations of task parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Satisfaction with Discharge Training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diabetes empowerment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in total dosage of GINA step 5 medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MVO/LV percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neurocognitive decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak-to-peak range of the frontal plane whole-body angular momentum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Gelsolin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute major wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Overall complication severity
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in surgery-free interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of self-sampling in clinic
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of self-sampling in clinic
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of self-sampling at home
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of self-sampling at home
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinically Significant Abnormalities in Laboratory Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self Reported Alcohol Consumption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Muscle oxygen saturation (SmO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who die within 72 hours after injury
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients who progress to require craniotomy due to epidural hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visual Analog Scale for pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disability due to low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Z-scores of weight for age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak VO2max with formula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality of life scale (HRLQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cognitive executive dysfunctions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Symptom incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-Mental State Examination score and grade
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hamilton depression score and grade
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants With Potentially Clinically Significant (PCS) Laboratory Values
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Potentially Clinically Significant (PCS) Electrocardiograms (ECGs) Findings
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Potentially Clinically Significant (PCS) Vital Sign Measurements
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Suicidal Ideation and Behaviour Using C-SSRS During the Open-Label Treatment Period
Endpoint domain: Adverse events/effects
Primary endpoint: Experiences of PNAs in implementing the role
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of antibiotic therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mayo Wrist Score (MWS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wrist strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulties in Emotion Regulation Scale - 16 item version (DERS-16)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Psychological Flexibility Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: safety of the index ablation procedure
Endpoint domain: Adverse events/effects
Primary endpoint: acute procedural success of the index ablation procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of mRS (0-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in challenging behaviors in the presence of medical stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes